Skip to Content

CAPECITABINE RELIANCE 150 MG FILM-COATED TABLETS

Active substance(s): CAPECITABINE

View full screen / Print PDF » Download PDF ⇩
Transcript
Capecitabine 150mg Pack Insert
Size: 400 mm x 180 mm (Front & Back)

Front Side

PACKAGE LEAFLET: INFORMATION FOR THE USER

Capecitabine Reliance 150mg film-coated tablets
Capecitabine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet (see section 4).
In this leaflet:
1. What Capecitabine Reliance is and what it is used for
2. What you need to know before you take Capecitabine Reliance
3. How to take Capecitabine Reliance
4. Possible side effects
5. How to store Capecitabine Reliance
6. Contents of the pack and other information
1. What Capecitabine Reliance is and what it is used for
Capecitabine Reliance belongs to the group of medicines called "cytostatic medicines", which stop the growth of cancer cells. Capecitabine Reliance
contains 150 mg capecitabine, which itself is not a cytostatic medicine. Only after being absorbed by the body is it changed into an active anti-cancer
medicine (more in tumor tissue than in normal tissue).
Capecitabine Reliance is used in the treatment of colon, rectal, gastric, or breast cancers.
Furthermore, Capecitabine Reliance is used to prevent new occurrence of colon cancer after complete removal of the tumor by surgery.
Capecitabine Reliance may be used either alone or in combination with other medicines.
2. What you need to know before you take Capecitabine Reliance
Do not take Capecitabine Reliance:
• if you are allergic to capecitabine or any of the other ingredients of this medicine (listed in section 6). You must inform your doctor if you know
that you have an allergy or over-reaction to this medicine,
• if you previously have had severe reactions to fluoropyrimidine therapy (a group of anticancer medicines such as fluorouracil),
• if you are pregnant or nursing,
• if you have severely low levels of white cells or platelets in the blood (leucopenia, neutropenia or thrombocytopenia), - if you have severe liver
or kidney problems,
• if you have a known deficiency for the enzyme dihydropyrimidine dehydrogenase (DPD) involved in the metabolism of uracil and thymine, or
if you are being treated now or have been treated in the last 4 weeks with brivudine, sorivudine or similar classes of substance as part of
herpes zoster (chickenpox or shingles) therapy.
Warnings and precautions
Talk to your doctor or pharmacist before taking Capecitabine Reliance
• if you have liver or kidney diseases
• if you have or had heart problems (for example an irregular heartbeat or pains to the chest jaw and back brought on by physical effort and due
to problems with the blood flow to the heart)
• if you have brain diseases (for example. cancer that has spread to the brain, or nerve damage (neuropathy)
• if you have calcium imbalances (seen in blood tests)
• if you have diabetes
• if you cannot keep food or water in your body because of severe nausea and vomiting
• if you have diarrhoea
• if you are or become dehydrated
• if you have imbalances of ions in your blood (electrolyte imbalances, seen in tests)
• if you have a history of eye problems as you may need extra monitoring of your eyes
• if you have a severe skin reaction.
DPD deficiency: DPD deficiency is a rare condition present at birth that is not usually associated with health problems unless you receive certain
medicines. If you have an unrecognized DPD deficiency and take Capecitabine Reliance, you may experience severe forms of the side effects listed under
section 4 possible side effects. Contact your doctor immediately if you are concerned about any of the side effects or if you notice any additional side
effects not listed in the leaflet (see section 4 possible side effects).
Children and adolescents
Capecitabine Reliance is not indicated in children and adolescents. Do not give Capecitabine Reliance to children and adolescents.
Other medicines and Capecitabine Reliance
Before starting treatment, tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is extremely
important, as taking more than one medicine at the same time can strengthen or weaken the effect of the medicines. You need to be particularly careful if
you are taking any of the following:
• gout medicines (allopurinol),
• blood-thinning medicines (coumarin, warfarin),
• certain anti-viral medicines (sorivudine and brivudine),
• medicines for seizures or tremors (phenytoin),
• interferon alpha ,
• radiotherapy and certain medicines used to treat cancer (folinic acid, oxaliplatin, bevacizumab, cisplatin, irinotecan),
• medicines used to treat folic acid deficiency.
Taking Capecitabine with food and drink:
You should take Capecitabine Reliance no later than 30 minutes after meals.
Pregnancy and breast-feeding
Before starting treatment, you must tell your doctor if you are pregnant, if you think you are pregnant or if you intend to become pregnant. You must not
take Capecitabine Reliance if you are pregnant or think you might be. You must not breast-feed if you are taking Capecitabine Reliance. Ask your doctor or
pharmacist for advice before taking this medicine.
Driving and using machines:
Capecitabine Reliance may make you feel dizzy, nauseous or tired. It is therefore possible that Capecitabine Reliance could affect your ability to drive a
car or operate machinery.
Capecitabine Reliance contains anhydrous lactose
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
3. How to take Capecitabine Reliance
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Capecitabine Reliance should only be prescribed by a doctor experienced in the use of anticancer medicines.
Capecitabine Reliance tablets should be swallowed whole with water and within 30 minutes of a meal.
Your doctor will prescribe a dose and treatment regimen that is right for you. The dose of Capecitabine Reliance is based on your body surface area. This
is calculated from your height and weight. The usual dose for adults is 1250 mg/m2 of body surface area taken two times daily (morning and evening).
Two examples are provided here: A person whose body weight is 64 kg and height is 1.64 m has a body surface area of 1.7 m2 and should take 4 tablets
of 500 mg and 1 tablet of 150 mg two times daily. A person whose body weight is 80 kg and height is 1.80 m has a body surface area of 2.00 m2 and
should take 5 tablets of 500 mg two times daily.
Capecitabine Reliance tablets are usually taken for 14 days followed by a 7 day rest period (when no tablets are taken). This 21 day period is one
treatment cycle.
In combination with other medicines the usual dose for adults may be less than 1250 mg/m2 of body surface area, and you may need to take the tablets
over a different time period (e.g. every day, with no rest period).
Your doctor will tell you what dose you need to take, when to take it and for how long you need to take it.
Your doctor may want you to take a combination of 150 mg and 500 mg tablets for each dose.
• Take the tablets morning and evening as prescribed by your doctor.
• Take the tablets within 30 minutes after the end of a meal (breakfast and dinner).
It is important that you take all your medicine as prescribed by your doctor.
If you take more Capecitabine Reliance than you should
If you take more Capecitabine Reliance than you should, contact your doctor as soon as possible before taking the next dose.
You might get the following side effects if you take a lot more capecitabine than you should: feeling or being sick, diarrhoea, inflammation or ulceration of
the gut or mouth, pain or bleeding from the intestine or stomach, or bone marrow depression (reduction in certain kinds of blood cells). Tell your doctor
immediately if you experience any of these symptoms.
If you forget to take Capecitabine:
Do not take the missed dose at all and do not double the next one. Instead, continue your regular dosing schedule and check with your doctor.
If you stop taking Capecitabine Reliance
There are no side effects caused by stopping treatment with capecitabine. In case you are using coumarin anticoagulants (containing e.g.
phenprocoumon), stopping capecitabine might require that your doctor adjusts your anticoagulant dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
STOP taking Capecitabine Reliance immediately and contact your doctor if any of these symptoms occur:
• Diarrhoea: if you have an increase of 4 or more bowel movements compared to your normal bowel movements each day or any diarrhoea
at night.
• Vomiting: if you vomit more than once in a 24-hour time period.

Capecitabine 150mg Pack Insert
Size: 400 mm x 180 mm (Front & Back)

Back Side

• Nausea: if you lose your appetite, and the amount of food you eat each day is much less than usual.
• Stomatitis: if you have pain, redness, swelling or sores in your mouth and/or throat.
• Hand-and-foot skin-reaction: if you have pain, swelling, redness or tingling of hands and/or feet.
• Fever: if you have a temperature of 38°C or greater.
• Infection: if you experience signs of infection caused by bacteria or virus, or other organisms.
• Chest pain: if you experience pain localised to the centre of the chest, especially if it occurs during exercise.
• Stevens-Johnson syndrome and toxic epidermal necrolysis: if you experience a painful red or purplish rash that spreads and blisters and/or other
lesions begin to appear in the mucous membranes (e.g. mouth and lips), in particular if this follows pain in the eyes on exposure to light, infections of the
respiratory system (e.g. bronchitis) and/or a high temperature.
If caught early, most of these side effects usually improve within 2 to 3 days after treatment discontinuation. If these side effects continue, however, contact
your doctor immediately. Your doctor may instruct you to restart treatment at a lower dose. If you develop symptoms that suggest the very serious
condition of Stevens-Johnson syndrome, this is a medical emergency and you must receive hospital treatment without delay. It is also important that
Capecitabine is stopped and not reintroduced even if the symptoms subside.
In addition to the above, when Capecitabine Reliance is used alone, very common side effects, which may affect more than 1 person in 10 are:
• abdominal pain
• rash, dry or itchy skin
• tiredness
• loss of appetite (anorexia)
These side effects can become severe; therefore, it is important that you always contact your doctor immediately when you start to experience a side
effect. Your doctor may instruct you to decrease the dose and/or temporarily discontinue treatment with Capecitabine Reliance. This will help reduce the
likelihood that the side effect continues or becomes severe.
Other side effects are:
Common side effects (may affect up to 1 in 10 people) include:
• decreases in the number of white blood cells or red blood cells (seen in tests)
• dehydration, weight loss
• sleeplessness (insomnia), depression
• headache, sleepiness, dizziness, abnormal sensation in the skin (numbness or tingling sensation), taste changes
• eye irritation, increased tears, eye redness (conjunctivitis)
• inflammation of the veins (thrombophlebitis),
• shortness of breath, nose bleeds, cough, runny nose
• cold sores or other herpes infections
• infections of the lungs or respiratory system (e.g. pneumonia or bronchitis)
• bleeding from the gut, constipation, pain in upper abdomen, indigestion, excess wind, dry mouth
• skin rash, hair loss (alopecia), skin reddening, dry skin, itching (pruritus), skin discolouration, skin loss, skin inflammation, nail disorder
• pain in the joints, or in the limbs (extremities), chest or back
• fever, swelling in the limbs, feeling ill
• problems with liver function (seen in blood tests) and increased blood bilirubin (excreted by the liver)
Uncommon side effects (may affect up to 1 in 100 people) include:
• blood infection, urinary tract infection, infection of the skin, infections in the nose and throat, fungal infections (including those of the
mouth), influenza, gastroenteritis, tooth abscess,
• lumps under the skin (lipoma)
• decreases in blood cells including platelets, thinning of blood (seen in tests)
• allergy
• diabetes, decrease in blood potassium, malnutrition, increased blood triglycerides
• confusional state, panic attacks, depressed mood, decreased libido
• difficulty speaking, impaired memory, loss of movement coordination, balance disorder, fainting, nerve damage (neuropathy) and problems
with sensation
• blurred or double vision
• vertigo, ear pain
• irregular heartbeat and palpitations (arrhythmias), chest pain and heart attack (infarction)
• blood clots in the deep veins, high or low blood pressure, hot flushes, cold limbs (extremities), purple spots on the skin
• blood clots in the veins in the lung (pulmonary embolism), collapsed lung, coughing up blood, asthma, shortness of breath on exertion
• bowel obstruction, collection of fluid in the abdomen, inflammation of the small or large intestine, the stomach or the oesophagus, pain in
the lower abdomen, abdominal discomfort, heartburn (reflux of food from the stomach), blood in the stool
• jaundice (yellowing of skin and eyes)
• skin ulcer and blister, reaction of the skin with sunlight, reddening of palms, swelling or pain of the face
• joint swelling or stiffness, bone pain, muscle weakness or stiffness
• fluid collection in the kidneys, increased frequency of urination during the night, incontinence, blood in the urine, increase in blood
creatinine (sign of kidney dysfunction)
• unusual bleeding from the vagina
• swelling (oedema), chills and rigors
Some of these side effects are more common when capecitabine is used with other medicines for the treatment of cancer. Other side-effects seen in this
setting are the following:
Common side effects (may affect up to 1 in 10 people) include:
• decrease in blood sodium, magnesium or calcium, increase in blood sugar
• nerve pain
• ringing or buzzing in the ears (tinnitus), loss of hearing
• vein inflammation
• hiccups, change in voice
• pain or altered/abnormal sensation in the mouth, pain in the jaw
• sweating, night sweats
• muscle spasm
• difficulty in urination, blood or protein in the urine
• bruising or reaction at the injection site (caused by medicines given by injection at the same time)
• Rare side effects (may affect up to 1 in 1,000 people) include:
• narrowing or blockage of tear duct (lacrimal duct stenosis)
• liver failure
• inflammation leading to dysfunction or obstruction in bile secretion (cholestatic hepatitis)
• specific changes in the electrocardiogram (QT prolongation)
• certain types of arrhythmia (including ventricular fibrillation, torsade de pointes, and bradycardia)
• eye inflammation causing eye pain and possibly eyesight problems
• inflammation of the skin causing red scaly patches due to an immune system illness
Very rare side effects (may affect up to 1 in 10,000 people) include:
severe skin reaction such as skin rash, ulceration and blistering which may involve ulcers of the mouth, nose, genitalia, hands, feet and eyes (red and
swollen eyes)
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side
effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Capecitabine Reliance
Keep this medicine out of the sight and reach of children.
Do not store above 30°C.
Do not use this medicine after the expiry date which is stated on the outer carton and label after EXP. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These
measures will help protect the environment.
6. Contents of the pack and other information
What Capecitabine Reliance contains
• The active substance is capecitabine (150 mg per film-coated tablet).
• The other ingredients are:
• Tablet core: anhydrous lactose, croscarmellose sodium, hypromellose, microcrystalline cellulose, magnesium stearate.
• Tablet coating: hypromellose, titanium dioxide (E171), macrogol/PEG, yellow and red iron oxide (E172), talc.
What Capecitabine Reliance tablets looks like and contents of the pack
Light peach colored film-coated, biconvex, oblong tablets having plain surface on both sides.
Capecitabine Reliance 150 mg film-coated tablet pack contains 60 film-coated tablets (6 blisters of 10 tablets).
For any information about this medicine, please contact: Telephone No. (24x7): +44 (0) 208 901 3370 Email id: safety@lambda-cro.com
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.

Marketing Authorisation Holder:
Reliance Genemedix Ltd.
Address: 8th FLOOR, 105 WIGMORE STREET
LONDON, W1U 1QY, Country: UK

Manufacturer:
Mawdsley Brooks and Co. Ltd
Unit 22, Quest Park, Wheatley hall Road,
Doncaster DN2 4LT UK

12000XXXXX V00

The leaflet was revised in 01/2016.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide